Ann Arbor-based ENDRA Life Sciences Inc. has been making waves in the field of clinical diagnostic ultrasound with its cutting-edge technology. The company specializes in the development of thermo-acoustic enhanced ultrasound technology, which enables the transmission of sound waves to bounce off tissues, organs, and blood in the body. This revolutionary technology has proven to be particularly effective in the treatment of nonalcoholic fatty liver disease, tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. In addition to its ultrasound technology, ENDRA Life Sciences Inc. also offers other diagnostic imaging technologies including computed tomography, magnetic resonance imaging, and ultrasound. These imaging modalities help physicians to non-invasively look inside a patient's body to gather information about medical conditions such as broken bones, cancers, signs of heart disease, or internal bleeding. To further advance its cutting-edge technology, ENDRA Life Sciences Inc. has entered into a collaborative research agreement with General Electric Company. Founded in 2007, the company is dedicated to developing and bringing to market innovative technologies that can improve patient outcomes and optimize healthcare delivery.